Insulet (PODD) Operating Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Insulet (PODD) Operating Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | -201.00 |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | 722.00 |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | 162.00 |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | 586.00 |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 736.00 |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | 887.00 |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | -1,075.00 |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | 963.00 |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 244.00 |
| 10 | Insulet | 9.31 Bn | 8.77 Bn | 562.60 Mn | 833.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 833.00 |
| Mar 31, 2026 | 829.00 |
| Dec 31, 2025 | 1,231.00 |
| Sep 30, 2025 | 1,581.00 |
| Jun 30, 2025 | 2,757.00 |
| Mar 31, 2025 | 278.00 |
| Dec 31, 2024 | 214.00 |
| Sep 30, 2024 | 397.00 |
| Jun 30, 2024 | 116.00 |
| Mar 31, 2024 | 642.00 |
| Dec 31, 2023 | 2,386.00 |
| Sep 30, 2023 | 249.00 |
| Jun 30, 2023 | -431.00 |
| Mar 31, 2023 | 395.00 |
| Dec 31, 2022 | -229.00 |
| Sep 30, 2022 | -800.00 |
| Jun 30, 2022 | -1,321.00 |
| Mar 31, 2022 | 826.00 |
| Dec 31, 2021 | 631.00 |
| Sep 30, 2021 | 768.00 |